4 startups found with PMF
The CRISPR category features pioneering biotechnology companies that leveraged gene-editing technology to solve complex problems in human health, agriculture, and industrial biology. These startups established the foundational product-market fit for genomic medicine before the current AI-driven drug discovery era. By studying these validated business models, founders can identify untapped niches and modernization opportunities within the life sciences sector.
A Disease Focused Biotech, Building Multiple Billion Dollar Drugs
Curative gene therapies for kidney diseases
Using CRISPR to find treatments for cancer and inflammation
Living therapies for pets first, and their people next
